Cost-effectiveness and budget impact analysis of infliximab and its biosimilar in patients with refractory moderate-to-severe Crohn's disease using real world evidence in Thailand
| Image |  |
|---|---|
| Description | scientific article published on 30 July 2020 |
| Author/s |
author: Chayanis Kositamongkol Pises Pisespongsa Phunchai Charatcharoenwitthaya Julajak Limsrivilai Satimai Aniwan Suporn Treepongkaruna Nathorn Chaiyakunapruk Pochamana Phisalprapa Taya Kitiyakara |
| Publication date | July 30, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |